Primary Site >> Liver Cancer

Gene >> PIK3CG

Journal: Hepatol Res. 2005 Oct;33(2):161-6.
Title: Hepatocyte-specific Pten-deficient mice as a novel model for nonalcoholic steatohepatitis and hepatocellular carcinoma.
Author: Watanabe, Sumio|Horie, Yasuo|Suzuki, Akira
PMID: 16214396
Journal: Oncogene. 2007 Jun 21;26(29):4272-83.
Title: FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway.
Author: Chen, C-H|Lu, P-J|Chen, Y-C|Fu, S-L|Wu, K-J|Tsou, A-P|Lee, Y-C G|Lin, T-C E|Hsu, S-L|Lin, W-J|Huang, C-Y F|Chou, C-K
PMID: 17237822
Journal: Biochem Biophys Res Commun. 2009 Sep 18;387(2):310-5.
Title: Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation.
Author: Ng, Stanley K L|Neo, Soek-Ying|Yap, Yann-Wan|Karuturi, R Krishna Murthy|Loh, Evelyn S L|Liau, Kui-Hin|Ren, Ee-Chee
PMID: 19591801
Journal: Expert Opin Pharmacother. 2010 Sep;11(13):2187-98.
Title: Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
Author: Yau, Thomas|Pang, Roberta|Chan, Pierre|Poon, Ronnie T
PMID: 20707757
Journal: J Clin Immunol. 2011 Feb;31(1):80-8.
Title: Nicotine stimulated dendritic cells could achieve anti-tumor effects in mouse lung and liver cancer.
Author: Gao, Feng Guang|Li, Hai Tao|Li, Zhi Jing|Gu, Jian Ren
PMID: 20957418
Journal: Eur J Surg Oncol. 2013 Sep;39(9):974-80.
Title: Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib.
Author: Chen, D|Zhao, P|Li, S Q|Xiao, W K|Yin, X Y|Peng, B G|Liang, L J
PMID: 23845703
Journal: Cancer Biol Ther. 2014 May;15(5):524-32.
Title: Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.
Author: Edling, Charlotte E|Selvaggi, Federico|Ghonaim, Ragheda|Maffucci, Tania|Falasca, Marco
PMID: 24521981
Journal: Front Physiol. 2014 Oct 15;5:391.
Title: Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts.
Author: Falasca, Marco|Maffucci, Tania
PMID: 25360116
Journal: Biochem Biophys Res Commun. 2015 Aug 21;464(2):500-5.
Title: miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma.
Author: Chen, Suling|Li, Fang|Chai, Haiyun|Tao, Xin|Wang, Haili|Ji, Aifang
PMID: 26163264
Journal: Pharmaceuticals (Basel). 2016 Mar 24;9(2). pii: ph9020018.
Title: A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.
Author: Tagaram, Hephzibah Rani S|Desai, Dhimant|Li, Guangfu|Liu, Dai|Rountree, C Bart|Gowda, Kavitha|Berg, Arthur|Amin, Shantu|Staveley-O'Carroll, Kevin F|Kimchi, Eric T
PMID: 27023566
Journal: Int J Biol Sci. 2016 Mar 25;12(5):594-606.
Title: Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental Validation.
Author: Zhang, Yanqiong|Lin, Ya|Zhao, Haiyu|Guo, Qiuyan|Yan, Chen|Lin, Na
PMID: 27143956
Journal: Lab Invest. 2017 Jan;97(1):53-69.
Title: ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca(2+)/PI3-kinase/AKT signaling pathway.
Author: Zhang, Yihao|Zhang, Ting|Wu, Chao|Xia, Quan|Xu, Dujuan
PMID: 27918554